FDA全球物质注册数据库(FDA Global Substance Registration System)

本页面为药物专论示例

,查询请从https://www.drugfuture.com/gsrs/开始。

物质名称TADALAFIL
异名/同义词(6R,12AR)-2,3,6,7,12,12A-HEXAHYDRO-2-METHYL-6-(3,4-(METHYLENEDIOXY)PHENYL) PYRAZINO(1',2':1,6)PYRIDO(3,4-B)INDOLE-1,4-DIONE
(6R-TRANS)-6-(1,3-BENZODIOXOL-5-YL)-2,3,6,7,12,12A-HEXAHYDRO-2-METHYL-PYRAZINO(1',2':1,6)PYRIDO(3,4-B)INDOLE-1,4-DIONE
CIALIS
ENTADFI COMPONENT TADALAFIL
IC351
IC-351
LY450190
LY-450190
NSC-750236
NSC-759172
OPSYNVI COMPONENT TADALAFIL
PYRAZINO(1',2':1,6)PYRIDO(3,4-B)INDOLE-1,4-DIONE, 6-(1,3-BENZODIOXOL-5-YL)-2,3,6,7,12,12A-HEXAHYDRO-2-METHYL-, (6R-12AR)-
TADALAFIL
TADALAFIL [EMA EPAR]
TADALAFIL [EP MONOGRAPH]
TADALAFIL [HSDB]
TADALAFIL [INN]
TADALAFIL [JAN]
TADALAFIL [MART.]
TADALAFIL [MI]
TADALAFIL [ORANGE BOOK]
TADALAFIL [USAN]
TADALAFIL [USP MONOGRAPH]
TADALAFIL [USP-RS]
TADALAFIL [VANDF]
TADALAFIL [WHO-DD]
TADALAFIL MYLAN
TRANS-TADALAFIL
CAS登记号171596-29-5
物质唯一标识(Unique Ingredient Identifier)742SXX0ICT
分子式C22H19N3O4
国际化合物标识(International Chemical Identifier,InChI)WOXKDUGGOYFFRN-IIBYNOLFSA-N
SMILESN12[C@@H](c3[nH]c4ccccc4c3C[C@@]1(C(=O)N(CC2=O)C)[H])c5cc6OCOc6cc5
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System